Plus Therapeutics to Present Data from Ongoing ReSPECT Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases (GlobeNewswire) - Jul 28, 2022 - "Plus Therapeutics, Inc....announced it will present data from two ongoing clinical trials for recurrent glioblastoma and leptomeningeal metastases at the 2022 Annual Conference on CNS Clinical Trials and Brain Metastases, co-sponsored by the Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO), being held August 12-13, 2022 in Toronto, Canada."
P1 data • P1/2 data • Brain Cancer • CNS Tumor • Glioma • Oncology
|